Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

89.81 +0.71 (+0.80%)
Streaming Delayed Price Updated: 11:30 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,095,840
Open 89.33
Bid (Size) 89.80 (200)
Ask (Size) 89.82 (300)
Prev. Close 89.10
Today's Range 89.11 - 89.91
52wk Range 61.24 - 89.43
Shares Outstanding N/A
Dividend Yield 1.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment ↗
Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics. 
Via Investor's Business Daily
News headline image
IonQ (IONQ) Surges on Strong Revenue Outlook and Insider Confidence Amidst Quantum Computing Race
November 14, 2025 – Quantum computing pioneer IonQ (NYSE: IONQ) recently captured significant market attention, with its stock experiencing a notable 3.6% gain on November 5, 2025, driven by an... 
Via MarketMinute
Topics Intellectual Property

Performance

YTD
+36.3%
+36.3%
1 Month
+6.0%
+6.0%
3 Month
+13.5%
+13.5%
6 Month
+28.9%
+28.9%
1 Year
+41.7%
+41.7%

More News

Read More
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
Via Benzinga
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
Eli Lilly And Novo Nordisk Ignite Bullish Retail Frenzy Ahead Of TrumpRx Deals To Slash Prices For Weight-Loss Drugs ↗
Via Stocktwits
News headline image
Why AstraZeneca Stock Was a Winner Today ↗
Via The Motley Fool
News headline image
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
Via TokenRing AI
Topics Artificial Intelligence
News headline image
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial ↗
Via Benzinga
News headline image
Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial
From AstraZeneca
Via Business Wire
News headline image
3 Reasons to Buy IonQ Stock Like There's No Tomorrow ↗
Via The Motley Fool
Topics Artificial Intelligence Fraud
News headline image
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease
From AstraZeneca
Via Business Wire
News headline image
Why AstraZeneca Stock Topped the Market on Thursday ↗
Via The Motley Fool
News headline image
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx ↗
Via Benzinga
Topics Government
News headline image
AstraZeneca Calms Pricing Jitters, Says US Deal Hit Absorbable ↗
Via Benzinga
News headline image
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
AstraZeneca Shares Jump; Drugmaker Keeps Outlook As Cancer Drug Sales Soar ↗
Via Investor's Business Daily
News headline image
AstraZeneca's 9M and Q3 2025 Financial Results
From AstraZeneca
Via Business Wire
News headline image
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Snowflake And SAP Bridge Enterprise Data Silos In Major AI Integration Push ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
News headline image
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
News headline image
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the Nasdaq Stock Market
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 89.81
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 11/17/25 11:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.